The Oncology Institute Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.
Frequently asked questions
To buy The Oncology Institute Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for The Oncology Institute Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for The Oncology Institute Inc. is TOI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
The Oncology Institute Inc. has its primary listing on NASDAQ (Small cap). You can trade The Oncology Institute Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, The Oncology Institute Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include The Oncology Institute Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like The Oncology Institute Inc..